Literature DB >> 7602074

The interaction between hepatitis B virus and hepatitis C virus in acute and chronic liver disease.

A Alberti1, P Pontisso, L Chemello, G Fattovich, L Benvegnù, F Belussi, M S De Mitri.   

Abstract

Infections by the hepatitis B or C virus are extremely common causes of acute and chronic liver disease, and coexistence of the two viruses in the same patient is not rare. Evidence has been found that such interaction may play an important role in fulminant hepatitis and in the development of hepatocellular carcinoma in cirrhotic patients. Liver disease activity and prognosis have been reported to be generally more serious in the presence of double infection, although an inverse relationship in the replicative levels of the two agents has been noted, suggesting viral interference, particularly in cases of chronic hepatitis. Thus, the two viruses seem to inhibit each other at the molecular level, while cytopathic effects appear to be enhanced. Further studies are needed to explain the mechanisms of these apparently contrasting effects.

Entities:  

Mesh:

Year:  1995        PMID: 7602074

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  31 in total

1.  Immunization needs of chronic liver disease patients seen in primary care versus specialist settings.

Authors:  R Jake Jacobs; Allen S Meyerhoff; Sammy Saab
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 2.  Hepatitis B reactivation during or after direct acting antiviral therapy - implication for susceptible individuals.

Authors:  Jacinta A Holmes; Ming-Lung Yu; Raymond T Chung
Journal:  Expert Opin Drug Saf       Date:  2017-05-19       Impact factor: 4.250

3.  Prevalence of anti-HCV antibodies in chronic liver disease in the Czech Republic.

Authors:  J Stránský; M Horejsová; A Chlumská; E Honzáková; J Vandasová; V Nĕmecek
Journal:  Infection       Date:  1997 Jan-Feb       Impact factor: 3.553

4.  Clinical course of chronic hepatitis C virus infection is not influenced by concurrent hepatitis G virus infection.

Authors:  J Hayashi; K Ueno; Y Kawakami; Y Kishihara; I Ariyama; N Furusyo; Y Sawayama; Y Etoh; S Kashiwagi
Journal:  Dig Dis Sci       Date:  1999-03       Impact factor: 3.199

Review 5.  Epidemiological and etiological variations in hepatocellular carcinoma.

Authors:  Evangelista Sagnelli; Margherita Macera; Antonio Russo; Nicola Coppola; Caterina Sagnelli
Journal:  Infection       Date:  2019-07-25       Impact factor: 3.553

6.  Response to hepatitis A and B vaccine alone or in combination in patients with chronic hepatitis C virus and advanced fibrosis.

Authors:  Erik Seth Kramer; Charlotte Hofmann; Paula G Smith; Mitchell L Shiffman; Richard K Sterling
Journal:  Dig Dis Sci       Date:  2009-06-11       Impact factor: 3.199

7.  Lesson from an intriguing case of cryoglobulinemia.

Authors:  Michele Barone; Raffaele Licinio; Annabianca Amoruso; Maria Teresa Viggiani; Angela Maria Vittoria Larocca; Alfredo Di Leo
Journal:  World J Gastroenterol       Date:  2013-01-14       Impact factor: 5.742

8.  Occult hepatitis B virus infection in Lebanese patients with chronic hepatitis C liver disease.

Authors:  S Ramia; A I Sharara; M El-Zaatari; F Ramlawi; Z Mahfoud
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2008-03       Impact factor: 3.267

9.  Acute hepatitis C virus (HCV) infection in chronic carriers of hepatitis B virus (HBV): the impact of underlying active HBV replication on persistence of HCV infection and antibody responses to HCV.

Authors:  C-M Chu; C T Yeh; I S Sheen; Y F Liaw
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

10.  High incidence of hepatitis C virus infection in hemodialysis patients in units with high prevalence.

Authors:  F H Pujol; J G Ponce; M G Lema; F Capriles; M Devesa; F Sirit; M Salazar; G Vásquez; F Monsalve; L Blitz-Dorfman
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.